Table 2.

Adjusted regression model results

Gene region of interest	ART group		SC group		Difference Estimatec	95% CI	p-value
	Na	Meanb	Na	Meanb
Lymphocyte samples
KvDMR	52	47.61	27	47.53	0.72	(-1.00, 2.45)	0.41
H19 CTCF3	53	42.16	27	41.70	0.66	(-0.94, 2.25)	0.42
H19 CTCF6	52	38.07	27	35.15	0.93	(-1.79, 3.65)	0.50
IGF2DMR0	53	50.04	26	48.32	0.08	(-1.82, 1.98)	0.94
IGF2R	52	69.26	27	72.13	-4.41	(-9.49, 0.66)	0.09
Buccal samples
KvDMR	64	53.46	29	52.60	1.60	(-2.77, 5.98)	0.47
H19 CTCF3	65	42.94	29	43.09	-0.24	(-2.96, 2.48)	0.86
H19 CTCF6	65	38.37	28	37.48	1.38	(-2.89, 5.64)	0.53
IGF2DMR0	65	36.52	27	35.03	2.07	(-0.28, 4.42)	0.08
IGF2R	65	79.45	29	81.35	-2.79	(-5.74, 0.16)	0.06

a Number of subjects included in the analysis

b The reported mean is averaged over all CpG sites in the region of interest

c Adjusted for pyrosequencing run, child's age, child's birth weight, child's sex, maternal age, maternal education, and household income